rs199474827
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Consequence
missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COX2 | unassigned_transcript_4802 | c.86T>A | p.Ile29Lys | missense_variant | Exon 1 of 1 | |||
TRNS1 | unassigned_transcript_4800 | c.-157A>T | upstream_gene_variant | |||||
COX1 | unassigned_transcript_4799 | c.*226T>A | downstream_gene_variant | |||||
TRND | unassigned_transcript_4801 | c.*86T>A | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|
Frequencies
GnomAD4 exome Cov.: 0
Mitomap
ClinVar
Submissions by phenotype
Mitochondrial complex IV deficiency, nuclear type 1 Pathogenic:1
- -
Mitochondrial disease Uncertain:1
The m.7671T>A (p.M29K) variant in MT-CO2 has been reported in two unrelated individuals with primary mitochondrial disease to date. The first individual was a 14 year old male with proximal myopathy, lactic acidosis, and a five year history of muscle weakness and fatigue. Skeletal muscle biopsies revealed severe COX deficiency, increased SDH staining, and absence of ragged red fibers. Variant heteroplasmy was 90% in muscle and 4.5% - 6% in blood. The second individual was a 48 year old male of European ancestry with mitochondrial myopathy characterized by progressive weakness. Serum creatine kinase levels were elevated and muscle biopsy revealed scattered COX-negative fibers with increased SDH staining. This variant was observed at 52% heteroplasmy, presumably in the muscle sample (PMID: 32800583). Haplogroup information was not reported for both cases precluding consideration for PS4. This variant occurred de novo in one individual (absent in blood from mother; PM6_supporting, PMID: 10486321). Single fiber testing showed higher levels of the variant in COX negative fibers (81%, n=13) than in COX positive fibers (45%, n=4), p<0.01 (PS3_supporting, PMID: 10486321). The computational predictors APOGEE1 and APOGEE2 give a consensus rating of pathogenic with raw scores of 0.90 and 0.942, respectively (Min=0, Max=1), which predict a damaging effect on gene function (PP3). This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on November 28, 2023. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PM6_supporting, PS3_supporting, PM2_supporting, PP3. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at